Oral contraceptivesBMJ 2001; 323 doi: https://doi.org/10.1136/bmj.323.7305.172/a (Published 21 July 2001) Cite this as: BMJ 2001;323:172
- Kamran Abbasi (email@example.com)
The debate over third generation oral contraceptives and venous thromboembolism has frequently surfaced in the BMJ in recent years, and the central dilemma has been how best to explain risk. James Drife's editorial (p 119) makes it all sound rather simple, and his analysis is about the clearest beacon in an ocean …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial